Starry Gene

Hefei, China · Founded 2019 · Privately Held (backing)

Developer of genetic modification technologies intended for therapeutic applications in ophthalmic disorders. Starry Gene is based in Hefei, China and was founded in 2019. Its last reported valuation was $11.9 million in Nov 2020. It has raised $4.5 million.

Last reported valuation
$11.9M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
—

Who backs Starry Gene?

10 investors
InvestorType
CAS StarOther
Hefei Industry Investment GroupVenture capital
Hefei Innovation Technology Venture CapitalOther
Hefei Hi-Tech VCVenture capital
Co-Win VenturesOther
CAS Investment ManagementVenture capital
Hefei XingTai Capital ManagementOther
KSCY Holding GroupOther
China Capital Zhongcai Fund Management—
Institute of Advanced Technology—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Starry Gene investors

Free account
More of Starry Gene with a free account
  • ·Watch Starry Gene: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Starry Gene. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View